MXCT 8-K 2026-11-10

MAXCYTE, INC. (MXCT) 8-K dated 2026-11-10 — accession 0001104659-26-124829.

MAXCYTE, INC. (MXCT) is a medical devices company listed on NASDAQ.

MXCT revenue $10.2M

This 8-K covers: Material agreement (Item 1.01), Results of operations (Item 2.02), Unregistered share sale (Item 3.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported MXCT revenue for 2025-12-31 was $33.0M. Net income was -$44.6M. Revenue was down 14.5% from 2024-12-31 to 2025-12-31. MXCT currently screens at market cap $124.3M.

Not investment advice. The MXCT SEC hub lists recent forms. The stock page is the research view.